Description
IGF-1LR3 1mg – Research Overview
IGF-1 LR3 1mg (Long Arg3 Insulin-like Growth Factor-1) is a modified analogue of insulin-like growth factor-1 (IGF-1). It contains structural modifications that distinguish it from naturally occurring IGF-1, including an extended amino-acid sequence and an amino-acid substitution.
IGF-1 LR3 is investigated in laboratory research relating to growth-factor receptor signalling, protein interactions and cellular responses.
Rejuva Labs supplies IGF-1 LR3 exclusively for laboratory and scientific research purposes.
Research Focus
Scientific research involving IGF-1 LR3 has explored:
- IGF-1 receptor interactions
- Cellular signalling pathways
- Growth-factor biology
- Protein binding and molecular interactions
- Cell proliferation and differentiation in experimental models
Research involving IGF-1 LR3 remains primarily experimental. Laboratory findings should not be interpreted as evidence of clinical safety or effectiveness.
Product Specifications
- Compound: IGF-1 LR3
- Full name: Long Arg3 Insulin-like Growth Factor-1
- Quantity: 1mg
- Form: Lyophilised (freeze-dried) powder, subject to supplier confirmation
- Packaging: Individually labelled research vial
- Batch identification: As supplied on the product packaging
- Storage: Follow the manufacturer’s validated storage instructions
Package Contents
- 1 × IGF-1 LR3 1mg research vial
- Batch identification information where supplied
- Supporting analytical documentation where available
Quality Assurance
Rejuva Labs provides a dedicated Batch Verification service, allowing customers to access available batch-specific Certificates of Analysis (COAs) using the batch number supplied with their product.
To access your documentation, visit our Batch Verification page and enter your batch number.
Disclaimer
For laboratory research use only. Not for human consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.